(Q48592039)

13 February 2018

title

Reduced dopamine turnover in the basal ganglia of depressed suicides. (English)

1 reference

13 February 2018

0 references

Bowden C

1

1 reference

13 February 2018

Cheetham SC

2

1 reference

13 February 2018

Lowther S

3

1 reference

13 February 2018

Katona CL

4

1 reference

13 February 2018

Crompton MR

5

1 reference

13 February 2018

Horton RW

6

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 September 1997

1 reference

13 February 2018

published in

Brain Research

1 reference

13 February 2018

volume

769

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

135-140

1 reference

13 February 2018

5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Correlation between cerebrospinal fluid amine metabolites and psychomotor activity in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Determination of monoamine and monoamine metabolites in the human brain: post mortem studies in a group of suicides and in a control group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Brain 5-HT2 receptor binding sites in depressed suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

New Tables for Multiple Comparisons with a Control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Variations of monoamines and their metabolites in the human brain putamen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Biogenic Amine Metabolites in Cerebrospinal Fluid of Depressed and Manic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Bromocriptine treatment of depressive disorders. Clinical and biochemical effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Serotonergic measures in suicide brain: the concentration of 5-HIAA, HVA, and tryptophan in frontal cortex of suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Increased dopamine-receptor sensitivity in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

5-hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900692-6

10.1016/S0006-8993(97)00692-6

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018